Search

Your search keyword '"Tim Dudderidge"' showing total 54 results

Search Constraints

Start Over You searched for: Author "Tim Dudderidge" Remove constraint Author: "Tim Dudderidge" Topic humans Remove constraint Topic: humans
54 results on '"Tim Dudderidge"'

Search Results

1. Reducing the Frequency of Follow-up Cystoscopy in Low-grade pTa Non–muscle-invasive Bladder Cancer Using the ADXBLADDER Biomarker

2. Focal therapy compared to radical prostatectomy for non-metastatic prostate cancer: a propensity score-matched study

3. False Positive Multiparametric Magnetic Resonance Imaging Phenotypes in the Biopsy-naïve Prostate: Are They Distinct from Significant Cancer-associated Lesions? Lessons from PROMIS

4. Comparison of the performances of the ADXBLADDER test and urinary cytology in the follow‐up of non‐muscle‐invasive bladder cancer: a blinded prospective multicentric study

5. Evaluation of functional outcomes after a second focal high-intensity focused ultrasonography (HIFU) procedure in men with primary localized, non-metastatic prostate cancer: results from the HIFU Evaluation and Assessment of Treatment (HEAT) registry

6. A Novel, non-invasive Test Enabling Bladder Cancer Detection in Urine Sediment of Patients Presenting with Haematuria—A Prospective Multicentre Performance Evaluation of ADXBLADDER

7. Magnetic Resonance Imaging and Targeted Biopsies Compared to Transperineal Mapping Biopsies Before Focal Ablation in Localised and Metastatic Recurrent Prostate Cancer After Radiotherapy

8. A prospective prostate cancer screening programme for men with pathogenic variants in mismatch repair genes (IMPACT): initial results from an international prospective study

10. Focal HIFU therapy for anterior compared to posterior prostate cancer lesions

11. Additional treatments to the local tumour for metastatic prostate cancer-assessment of novel treatment algorithms (IP2-ATLANTA): protocol for a multicentre, phase II randomised controlled trial

12. Cancer Control Outcomes Following Focal Therapy Using High-intensity Focused Ultrasound in 1379 Men with Nonmetastatic Prostate Cancer: A Multi-institute 15-year Experience

13. Conventional radical versus focal treatment for localised prostate cancer: a propensity score weighted comparison of 6-year tumour control

14. PROState Pathway Embedded Comparative Trial: The IP3-PROSPECT study

15. A critical evaluation of visual proportion of Gleason 4 and maximum cancer core length quantified by histopathologists

16. Comparative healthcare research outcomes of novel surgery in prostate cancer (IP4-CHRONOS): a prospective, multi-centre therapeutic phase II parallel randomised control trial

17. An Exploratory Study of Dose Escalation

18. What Type of Prostate Cancer Is Systematically Overlooked by Multiparametric Magnetic Resonance Imaging? An Analysis from the PROMIS Cohort

19. Prostate Specific Antigen Criteria to Diagnose Failure of Cancer Control following Focal Therapy of Nonmetastatic Prostate Cancer Using High Intensity Focused Ultrasound

20. Diagnostic Accuracy of MCM5 for the Detection of Recurrence in Nonmuscle Invasive Bladder Cancer Followup: A Blinded, Prospective Cohort, Multicenter European Study

21. Retrospective evaluation of whole exome and genome mutation calls in 746 cancer samples

22. Metastatic prostate cancer men’s attitudes towards treatment of the local tumour and metastasis evaluative research (IP5-MATTER): protocol for a prospective, multicentre discrete choice experiment study

23. Interim Results from the IMPACT Study: Evidence for Prostate-specific Antigen Screening in BRCA2 Mutation Carriers

24. Overcoming difficulties with equipoise to enable recruitment to a randomised controlled trial of partial ablation vs radical prostatectomy for unilateral localised prostate cancer

25. Establishing MRI-guided prostate intervention at a UK Centre

26. The role of targeted prophylactic antimicrobial therapy before transrectal ultrasonography-guided prostate biopsy in reducing infection rates: a systematic review

27. Multiparametric MRI to improve detection of prostate cancer compared with transrectal ultrasound-guided prostate biopsy alone: the PROMIS study

28. Sequencing of prostate cancers identifies new cancer genes, routes of progression and drug targets

29. Nephron-sparing surgery across a nation - outcomes from the British Association of Urological Surgeons 2012 national partial nephrectomy audit

30. Partial ablation versus radical prostatectomy in intermediate-risk prostate cancer: the PART feasibility RCT

31. Appraising the relevance of DNA copy number loss and gain in prostate cancer using whole genome DNA sequence data

32. A Multicentre Study of 5-year Outcomes Following Focal Therapy in Treating Clinically Significant Nonmetastatic Prostate Cancer

33. Positive messages for bladder cancer management in negative sentinel lymph node study

34. Mutational signatures of ionizing radiation in second malignancies

35. Identification of 23 new prostate cancer susceptibility loci using the iCOGS custom genotyping array

36. Donor-derived human herpes virus 8-related Kaposi's sarcoma in renal allograft ureter

37. Analysis of the genetic phylogeny of multifocal prostate cancer identifies multiple independent clonal expansions in neoplastic and morphologically normal prostate tissue

39. Evolution of the Southampton Enhanced Recovery Programme for radical cystectomy and the aggregation of marginal gains

40. Surgical Repair of Idiopathic Scrotal Elephantiasis

41. Evaluation of ideal irrigation fluid in ‘Greenlight’ photoselective vapourization of the prostate

42. A meta-analysis of genome-wide association studies to identify prostate cancer susceptibility loci associated with aggressive and non-aggressive disease

43. Rare Case of Primary Lymphoma of the Prostate: Giving the Patient the Benefit of the Doubt

44. Bladder cancer diagnosis and identification of clinically significant disease by combined urinary detection of Mcm5 and nuclear matrix protein 22

45. Evolution of care pathway for laparoscopic radical prostatectomy

46. Diagnosis of prostate cancer by detection of minichromosome maintenance 5 protein in urine sediments

47. High-intensity-focused ultrasound in the treatment of primary prostate cancer: the first UK series

48. Urology led ultrasound services--time to focus

49. An algorithm for managing the failure of external beam radiotherapy in prostate cancer

50. Mitogenic growth signalling, DNA replication licensing, and survival are linked in prostate cancer

Catalog

Books, media, physical & digital resources